Illumina's (Solexa) Genome Analyzer. By the time Solexa Ltd. announced its plans to merge with Lynx Therapeutics in August 2004, a lot of the core sequencing-by-synthesis chemistry and molecular ...

After all, Illumina has dominated the next-gen sequencing (NGS) space for close to 15 years, has incredibly strong fundamentals and still controls a decisive majority of the NGS market ...

Readouts corresponding to the detected molecules can be generated with sequencing-by-synthesis instruments, such as Illumina and Oxford Nanopore Technologies (ONT). However, errors may occur ...

The Genomics Core now has an Illumina NextSeq500 Next Generation Sequencing (NGS) instrument! This will expand our capacity of services already offered for NGS. Feel free to call or email us to find ...

The MiSeq desktop sequencer offers low throughput flowcells and long read lengths. It is best for small whole-genome sequencing, targeted gene sequencing, metagenomics, and CRISPR validation. The ...

This image illustrates the typical steps in next-generation sequencing (excluding single-molecule sequencing methods). The process begins with isolating genomic DNA (a) and breaking it into short ...

BRUSSELS, Sept 3 (Reuters) - U.S. gene sequencing company Illumina (ILMN.O), opens new tab on Tuesday won its court fight against the European Union's investigation ...

By combining Biosearch Technologies' targeted genotyping-by-sequencing library preparation methodology (Amp-Seq) with Illumina's proven and highly scalable sequencing technology, the partnership ...

Illumina, a leader in DNA sequencing and array-based technologies, is set to enhance the genomic sciences landscape in India by establishing a new Global Capability Center (GCC) in Bengaluru. This ...

27, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Food and Drug Administration (FDA) approval of its in vitro ...

Illumina Inc. a global leader in DNA sequencing and array-based technologies, announced at the Illumina India Genomics Summit that it will establish a Global Capability Center in Bengaluru, India, as ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...